Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC 38A7 and ALPPL 2

Author:

Dudenkov Tanda M.1,Liu Duan1ORCID,Cairns Junmei1ORCID,Devarajan Sandhya1,Zhuang Yongxian1,Ingle James N.2ORCID,Buzdar Aman U.3,Robson Mark E.4,Kubo Michiaki5,Batzler Anthony6,Barman Poulami6,Jenkins Gregory D.6,Carlson Erin E.6,Goetz Matthew P.2,Northfelt Donald W.7,Moreno‐Aspitia Alvaro8,Desta Zeruesenay9,Reid Joel M.1,Kalari Krishna R.6,Wang Liewei1,Weinshilboum Richard M.1ORCID

Affiliation:

1. Division of Clinical PharmacologyDepartment of Molecular Pharmacology and Experimental TherapeuticsMayo Clinic Rochester Minnesota USA

2. Division of Medical OncologyDepartment of OncologyMayo Clinic Rochester Minnesota USA

3. Department of Breast OncologyMD Anderson Cancer Center Houston Texas USA

4. Breast Medicine ServiceMemorial Sloan Kettering Cancer Center New York New York USA

5. RIKEN Center for Integrative Medical Sciences Yokohama City Japan

6. Division of Biomedical Statistics and InformaticsDepartment of Health Sciences ResearchMayo Clinic Rochester Minnesota USA

7. Division of Hematology/OncologyDepartment of Internal MedicineMayo Clinic Scottsdale Arizona USA

8. Division of Hematology/OncologyDepartment of Internal MedicineMayo Clinic Jacksonville Florida USA

9. Division of Clinical PharmacologyDepartment of MedicineIndiana University School of Medicine Indianapolis Indiana USA

Funder

Breast Cancer Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. ‘Arimidex’ (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview

2. History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target

3. Kane S.P.Anastrozole ClinCalc DrugStats Database Version 17.0. ClinCalc (2017).

4. National Institute for Health and Care Excellence.Familial breast cancer: classification care and managing breast cancer and related risks in people with a family history of breast cancer. Clinical guideline [CG164] (2017).

5. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3